Found 19 matching trials
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC N/A This is an external control, observational, retrospective study designed to...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II N/A A national, prospective, multi-center, open-label, multi-cohort study compr...
Show More Location
Soonchunhyang University Hospital Bucheon
Learn More & Join Trial
Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC N/A This is a global, multicenter, open-label pre-approval access program to pr...
Show More Status
Approved For Marketing
Location
Multiple Locations
Learn More & Join Trial
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) PHASE3 This is an international, randomized, open-label, Phase 3 study designed to...
Show More Location
Hospital Britanico
Learn More & Join Trial
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation PHASE2 The purpose of this study is to assess the Treatment Strategies and Surviva...
Show More Learn More & Join Trial
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors PHASE1 This is a Phase 1/2, open-label, first-in-human (FIH) study designed to eva...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer PHASE4 This is a retrospective and prospective real-world clinical study of molecu...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC) PHASE2 This trial will evaluate the efficacy and safety of various therapies in pa...
Show More Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer PHASE2 The current study aims to explore the potential advantages of anti-cancer t...
Show More Location
West China hospital
Learn More & Join Trial
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study PHASE2 TAPISTRY is a Phase II, global, multicenter, open-label, multi-cohort study...
Show More Status
Active Not Recruiting
Location
Western Regional Medical Center at Cancer Treatment Centers of America
Learn More & Join Trial